TTP Extends Global Reach
News Apr 04, 2007
Success of mosquito® and Acumen® eX3 leads new distribution agreements for Japan, India and Australia/New Zealand.
After building up a strong base of customers in the USA and Europe over the past three years, TTP LabTech have now appointed distributors for Japan (AsOne Corporation, Osaka), India (Wipro Limited, Biomed Division, Bangalore), and Australia/New Zealand (Millennium Science, Victoria).
Covering LabTech’s nanolitre liquid handler, mosquito®, and their new microplate cytometer, Acumen® eX3, these exclusive agreements have already led to multiple sales in these territories.
Commenting on the new appointments, Jas Sanghera, TTP LabTech’s Commercial Director, said “mosquito and the Acumen eX3 both have enviable reputations and are seen as first choice instruments in a number of application areas. With an established customer base in our traditional markets and high capacity manufacturing capabilities, we felt the time was right to expand globally.
Having been approached by a number of possible distributors we have signed agreements with companies that really fit with the TTP LabTech ethos; they understand the researcher’s needs and have a reputation for excellent customer service and support.”
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
New Algorithms Help Extract 3-D Biological Structure from Limited DataNews
CAMERA researchers capitalize on their Multi-Tiered Iterative Phasing approach to determine molecular structure of proteins and viruses from X-ray free electron laser data.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018